Mackenzie Financial Corp Mannkind Corp Transaction History
Mackenzie Financial Corp
- $66.8 Billion
- Q3 2024
A detailed history of Mackenzie Financial Corp transactions in Mannkind Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 32,528 shares of MNKD stock, worth $228,346. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,528
Previous 32,848
0.97%
Holding current value
$228,346
Previous $171,000
19.3%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MNKD
# of Institutions
244Shares Held
148MCall Options Held
1.62MPut Options Held
802K-
Black Rock Inc. New York, NY22.6MShares$158 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.6MShares$110 Million0.0% of portfolio
-
State Street Corp Boston, MA9.6MShares$67.4 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY9.16MShares$64.3 Million6.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$61.4 Million0.83% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.81B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...